PUBLICATIONS · 18829514
A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2008 Oct 1
- First author
- Hensley ML
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hensley ML
- type
- Author
- name
- Larkin J
- type
- Author
- name
- Fury M
- type
- Author
- name
- Gerst S
- type
- Author
- name
- Tai DF
- type
- Author
- name
- Sabbatini P
- type
- Author
- name
- Konner J
- type
- Author
- name
- Orlando M
- type
- Author
- name
- Goss TL
- type
- Author
- name
- Aghajanian CA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hensley ML
- type
- Author
- name
- Larkin J
- type
- Author
- name
- Fury M
- type
- Author
- name
- Gerst S
- type
- Author
- name
- Tai DF
- type
- Author
- name
- Sabbatini P
- type
- Author
- name
- Konner J
- type
- Author
- name
- Orlando M
- type
- Author
- name
- Goss TL
- type
- Author
- name
- Aghajanian CA
- type
- Author
- bibliography ids
- nci-bib-f24737f3077e38abb1f0ff33
- book metadata
- content sha256
- d608c41706c500240aad13c151fb00d06bd6e88fabac9c1aee7e7470ade96667
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-08-0338
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18829514
- immutable id
- pubmed:18829514@d608c41706c500240aad13c151fb00d06bd6e88fabac9c1aee7e7470ade96667
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- Source null
- issn print
- 1078-0432
- issue
- 19
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 6310-6
- volume
- 14
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18829514
- provenance
- batch id
- 6281e3e555c9a831cffc
- provider
- NCBI PubMed ESummary
- record sha256
- 01bd810f826c5d1a5e0afcdbc878a5b577b5accd686ef729b9c4fbe60fd5c5be
- response sha256
- 0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
- retrieved at
- 2026-09-09T23:46:21.772457+00:00
- publication date
- display
- 2008 Oct 1
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase I
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
Preserved source evidence · Not medical advice
Triangle